Labcorp Holdings Inc. (FRA:N6B)

Market Cap	17.95B
Revenue (ttm)	11.73B
Net Income (ttm)	728.89M
Shares Out	n/a
EPS (ttm)	8.68
PE Ratio	24.62
Forward PE	14.58
Dividend	2.57 (1.19%)
Ex-Dividend Date	Nov 26, 2025

Volume	n/a
Average Volume	2
Open	216.00
Previous Close	216.00
Day's Range	216.00 - 216.00
52-Week Range	183.00 - 248.00
Beta	n/a
RSI	44.95
Earnings Date	Feb 5, 2026

About Labcorp Holdings

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target...

• Industry: Medical Laboratories
• Founded: 1995
• Employees: 70,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: N6B

Financial Performance

In 2024, Labcorp Holdings's revenue was $13.01 billion, an increase of 6.97% compared to the previous year's $12.16 billion. Earnings were $746.00 million, an increase of 78.47%.

Financial numbers in USD